Heading,Source,Date,Symbol
Best Pharma Stock: Laurus Labs vs Divis Labs,Equitymaster,3 Apr 2024,DIVISLAB
"Divi's Labs: Downgrade cycle over! BofA upgrades stock to Buy, shares target price",Business Today,4 Apr 2024,DIVISLAB
"Divi's Labs inks long-term supply deal, plans up to Rs 700-crore capacity addition",Moneycontrol,25 Apr 2024,DIVISLAB
Divi's Laboratories to expand capacity at an outlay of approx. Rs. 700 Cr,Indian Pharma Post,26 Apr 2024,DIVISLAB
Divi’s Labs Enters Long-Term Supply Agreement,Machine Maker,26 Apr 2024,DIVISLAB
Stock Market Highlights: Nifty hourly momentum indicator triggers positive crossover; positive momentum m...,The Economic Times,25 Apr 2024,DIVISLAB
"High base, change in product mix to weigh on life insurers' margin in Q4",Business Standard,9 Apr 2024,DIVISLAB
"Share Market Highlights 3rd April 2024: Sensex, Nifty trade flat amid global stock decline; IT stocks shine",BusinessLine,3 Apr 2024,DIVISLAB
"Stock Market Highlight: Markets close lower! Nifty near 22,500, Sensex dips over 800 points; Nifty Bank slips 470 points",Financial Express,12 Apr 2024,DIVISLAB
Contract Manufacturing: Pharma’s New Growth Pill,Fortune India,1 Apr 2024,DIVISLAB
